Mudita Advisors LLP Increases Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Mudita Advisors LLP raised its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 16.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 414,500 shares of the company's stock after purchasing an additional 59,699 shares during the quarter. Establishment Labs accounts for about 10.7% of Mudita Advisors LLP's portfolio, making the stock its 3rd largest position. Mudita Advisors LLP owned about 1.48% of Establishment Labs worth $19,096,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Brown Advisory Inc. increased its position in Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock valued at $107,729,000 after purchasing an additional 438,057 shares during the period. Capital Research Global Investors lifted its position in Establishment Labs by 29.3% during the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after acquiring an additional 433,484 shares during the last quarter. Voya Investment Management LLC lifted its position in Establishment Labs by 7,249.5% during the fourth quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock valued at $18,809,000 after acquiring an additional 402,707 shares during the last quarter. Millennium Management LLC lifted its position in Establishment Labs by 96.9% during the fourth quarter. Millennium Management LLC now owns 711,691 shares of the company's stock valued at $32,788,000 after acquiring an additional 350,213 shares during the last quarter. Finally, Findell Capital Management LLC increased its holdings in shares of Establishment Labs by 28.5% during the fourth quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock valued at $62,032,000 after acquiring an additional 298,380 shares in the last quarter. Institutional investors own 72.91% of the company's stock.

Establishment Labs Trading Down 1.3%

ESTA traded down $0.46 during trading on Friday, hitting $36.16. 305,093 shares of the company's stock were exchanged, compared to its average volume of 470,272. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $59.00. The firm has a market cap of $1.05 billion, a P/E ratio of -14.02 and a beta of 0.73. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The stock has a 50 day moving average price of $34.41 and a 200 day moving average price of $38.26.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. During the same period in the prior year, the business posted ($0.58) EPS. The business's revenue was up 11.3% on a year-over-year basis. As a group, analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ESTA has been the subject of a number of recent research reports. Needham & Company LLC raised shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price target for the company in a research report on Wednesday. BTIG Research initiated coverage on shares of Establishment Labs in a research report on Friday. They set a "buy" rating and a $62.00 price objective for the company. Finally, Stephens restated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, Establishment Labs presently has a consensus rating of "Moderate Buy" and an average price target of $55.33.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.